Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04491942
Title	Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	National Cancer Institute (NCI)
Indications	lung small cell carcinoma endometrial cancer lung non-small cell carcinoma stomach cancer cervical cancer transitional cell carcinoma esophageal cancer triple-receptor negative breast cancer malignant pleural mesothelioma ovarian cancer Advanced Solid Tumor penile cancer biliary tract cancer head and neck cancer
Therapies	Cisplatin + Elimusertib Cisplatin + Elimusertib + Gemcitabine
Age Groups:	adult \| senior
Covered Countries	USA \| CAN